首页 > 最新文献

Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery最新文献

英文 中文
Surgical approach to complicated transcatheter aortic valve implantation endocarditis. 复杂经导管主动脉瓣植入性心内膜炎的手术入路。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-07-21 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.26945
Burak Bozkurt, İsmail Yücesin Arslan, Mukan Kağan Kuş, Talib Durak, Mehmet Kaplan
{"title":"Surgical approach to complicated transcatheter aortic valve implantation endocarditis.","authors":"Burak Bozkurt, İsmail Yücesin Arslan, Mukan Kağan Kuş, Talib Durak, Mehmet Kaplan","doi":"10.5606/tgkdc.dergisi.2025.26945","DOIUrl":"10.5606/tgkdc.dergisi.2025.26945","url":null,"abstract":"","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"391-394"},"PeriodicalIF":0.5,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421567/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute histopathological and biochemical changes in saphenous vein grafts during coronary artery bypass grafting: A closer look at mTOR signaling. 冠状动脉旁路移植术中隐静脉移植物的急性组织病理学和生化变化:mTOR信号的进一步观察。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-07-21 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.27697
Hasan Cihan, Burak Toprak, Abdulkadir Bilgiç

Background: This study aims to investigate whether acute surgical manipulation of great saphenous vein grafts during coronary artery bypass grafting alters mammalian target of rapamycin (mTOR) activation and induces early histopathological damage.

Methods: Between September 2022 and September 2023, a total of 44 elective coronary artery bypass grafting patients (38 males, 6 females; mean age: 60.8±8.3 years; range, 36 to 70 years) were included in this prospective study. Saphenous vein segments were collected pre- and post-preparation. Light microscopy and enzyme-linked immunosorbent assay were used to assess structural changes and mTOR levels.

Results: Histopathological analyses revealed endothelial disruption and subendothelial inflammatory infiltration in post-preparation samples. However, mTOR protein levels showed no significant difference between pre- and post-manipulation tissues (p=0.41).

Conclusion: Mechanical stress during great saphenous vein graft preparation causes notable endothelial injury, but does not acutely activate the mTOR pathway. These findings suggest that mTOR may not participate in early responses, but could be implicated in long-term vascular remodeling.

背景:本研究旨在探讨冠状动脉搭桥术中大隐静脉移植的急性手术操作是否会改变哺乳动物雷帕霉素靶蛋白(mTOR)的激活并诱导早期组织病理学损伤。方法:本前瞻性研究于2022年9月至2023年9月共纳入44例择期冠状动脉旁路移植术患者,其中男性38例,女性6例,平均年龄60.8±8.3岁,年龄范围36 ~ 70岁。在预备前后分别收集隐静脉段。使用光镜和酶联免疫吸附法评估结构变化和mTOR水平。结果:组织病理学分析显示制备后样品内皮破坏和内皮下炎症浸润。然而,mTOR蛋白水平在操作前后组织间无显著差异(p=0.41)。结论:大隐静脉移植制备过程中机械应力引起明显的内皮损伤,但不会急性激活mTOR通路。这些发现表明mTOR可能不参与早期反应,但可能与长期血管重塑有关。
{"title":"Acute histopathological and biochemical changes in saphenous vein grafts during coronary artery bypass grafting: A closer look at mTOR signaling.","authors":"Hasan Cihan, Burak Toprak, Abdulkadir Bilgiç","doi":"10.5606/tgkdc.dergisi.2025.27697","DOIUrl":"10.5606/tgkdc.dergisi.2025.27697","url":null,"abstract":"<p><strong>Background: </strong>This study aims to investigate whether acute surgical manipulation of great saphenous vein grafts during coronary artery bypass grafting alters mammalian target of rapamycin (mTOR) activation and induces early histopathological damage.</p><p><strong>Methods: </strong>Between September 2022 and September 2023, a total of 44 elective coronary artery bypass grafting patients (38 males, 6 females; mean age: 60.8±8.3 years; range, 36 to 70 years) were included in this prospective study. Saphenous vein segments were collected pre- and post-preparation. Light microscopy and enzyme-linked immunosorbent assay were used to assess structural changes and mTOR levels.</p><p><strong>Results: </strong>Histopathological analyses revealed endothelial disruption and subendothelial inflammatory infiltration in post-preparation samples. However, mTOR protein levels showed no significant difference between pre- and post-manipulation tissues (p=0.41).</p><p><strong>Conclusion: </strong>Mechanical stress during great saphenous vein graft preparation causes notable endothelial injury, but does not acutely activate the mTOR pathway. These findings suggest that mTOR may not participate in early responses, but could be implicated in long-term vascular remodeling.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"279-287"},"PeriodicalIF":0.5,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421562/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modified Blalock-Taussig-Thomas shunt blockage and mortality: A systematic review and meta-analysis. 改良Blalock-Taussig-Thomas分流阻塞与死亡率:一项系统回顾和荟萃分析。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-07-21 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.26521
Adli Daffa Ikhwani, Amar Rayhan, Suprayitno Wardoyo

Background: In this systematic review and meta-analysis, we discuss the estimated of global incidence, shunt related-mortality risk and factors associated with shunt blockage after modified Blalock-Taussig-Thomas (mBTT) procedure.

Methods: A systematic review and meta-analysis were conducted using PubMed, ScienceDirect, and EMBASE up to February 2024. The primary outcomes were the incidence and mortality risk associated with shunt blockage. Additional outcomes included study characteristics, surgical factors, and coagulation profiles. Single and two-group proportional meta-analyses were performed.

Results: A total of 25 studies involving 2,677 patients were included. The global incidence of shunt blockage was 7% (95% confidence interval [CI]: 0.05 to 0.10) with high heterogeneity (I2 =81%; p<0.01). In 15 studies eligible for mortality analysis, patients with shunt blockage had significantly higher odds of death (odds ratio [OR]=5.04; 95% CI: 2.69 to 9.44) with low heterogeneity (I2 =3%; p=0.41). Shunt size alone was not a significant predictor of blockage. However, patients with shunt blockage exhibited significantly lower partial thromboplastin time and activated partial thromboplastin time values, suggesting coagulation abnormalities. No significant difference was found in platelet counts.

Conclusion: Shunt blockage is a critical complication following mBTT shunt, significantly increasing mortality risk. While shunt size is not independently predictive, multiple factors, including patient weight, underlying pathology, coagulation profile, surgical factors, and shunt size-to-weight ratio, may contribute to thrombosis risk and warrant further investigation.

背景:在这篇系统综述和荟萃分析中,我们讨论了改良Blalock-Taussig-Thomas (mBTT)手术后全球发生率、分流管相关死亡风险和分流管阻塞相关因素的估计。方法:截至2024年2月,使用PubMed、ScienceDirect和EMBASE进行系统评价和荟萃分析。主要结局是与分流管堵塞相关的发生率和死亡率风险。其他结果包括研究特征、手术因素和凝血情况。进行单组和两组比例荟萃分析。结果:共纳入25项研究,涉及2677例患者。分流管阻塞的全球发生率为7%(95%可信区间[CI]: 0.05 ~ 0.10),异质性高(I2 =81%; pI2 =3%; p=0.41)。单独的分流管大小并不是阻塞的显著预测因子。然而,分流阻塞的患者表现出明显较低的部分凝血活素时间和活化的部分凝血活素时间值,提示凝血异常。血小板计数无明显差异。结论:分流管堵塞是mBTT分流术的重要并发症,显著增加死亡风险。虽然分流管的大小不能独立预测,但包括患者体重、基础病理、凝血情况、手术因素和分流管的大小与重量比在内的多种因素都可能导致血栓形成风险,值得进一步研究。
{"title":"Modified Blalock-Taussig-Thomas shunt blockage and mortality: A systematic review and meta-analysis.","authors":"Adli Daffa Ikhwani, Amar Rayhan, Suprayitno Wardoyo","doi":"10.5606/tgkdc.dergisi.2025.26521","DOIUrl":"10.5606/tgkdc.dergisi.2025.26521","url":null,"abstract":"<p><strong>Background: </strong>In this systematic review and meta-analysis, we discuss the estimated of global incidence, shunt related-mortality risk and factors associated with shunt blockage after modified Blalock-Taussig-Thomas (mBTT) procedure.</p><p><strong>Methods: </strong>A systematic review and meta-analysis were conducted using PubMed, ScienceDirect, and EMBASE up to February 2024. The primary outcomes were the incidence and mortality risk associated with shunt blockage. Additional outcomes included study characteristics, surgical factors, and coagulation profiles. Single and two-group proportional meta-analyses were performed.</p><p><strong>Results: </strong>A total of 25 studies involving 2,677 patients were included. The global incidence of shunt blockage was 7% (95% confidence interval [CI]: 0.05 to 0.10) with high heterogeneity (<i>I<sup>2</sup></i> =81%; p<0.01). In 15 studies eligible for mortality analysis, patients with shunt blockage had significantly higher odds of death (odds ratio [OR]=5.04; 95% CI: 2.69 to 9.44) with low heterogeneity (<i>I<sup>2</sup></i> =3%; p=0.41). Shunt size alone was not a significant predictor of blockage. However, patients with shunt blockage exhibited significantly lower partial thromboplastin time and activated partial thromboplastin time values, suggesting coagulation abnormalities. No significant difference was found in platelet counts.</p><p><strong>Conclusion: </strong>Shunt blockage is a critical complication following mBTT shunt, significantly increasing mortality risk. While shunt size is not independently predictive, multiple factors, including patient weight, underlying pathology, coagulation profile, surgical factors, and shunt size-to-weight ratio, may contribute to thrombosis risk and warrant further investigation.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"329-340"},"PeriodicalIF":0.5,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcatheter fenestration in Fontan failure: Our clinical experience. 经导管开窗治疗Fontan衰竭的临床经验。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-07-21 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.27159
Ensar Duras, Recep Siyar Balik, Perver Arslan, Erman Cilsal, Murat Sahin, Ibrahim Cansaran Tanidir, Yakup Ergul, Alper Guzeltas

Background: The aim of our study was to evaluate the hemodynamic effects and clinical outcomes of transcatheter fenestration in patients who developed Fontan failure.

Methods: Between January 2014 and December 2022, among a total of 187 patients undergoing the Fontan operation, 10 (6 males, 4 females; median age: 10.9 years; range, 4.2 to 23 years) who underwent transcatheter creation or dilation of a Fontan fenestration due to the development of Fontan failure were retrospectively analyzed. Demographic data, laboratory results, echocardiographic findings, and catheterization parameters of the patients were recorded. The patients were classified into two groups based on the timing of Fontan failure: those who underwent fenestration before hospital discharge constituted the early-stage group, while those who underwent fenestration after discharge were assigned to the late-stage group. These two groups were compared in terms of hemodynamic parameters, changes in oxygen saturation, and complication rates.

Results: Transcatheter fenestration was performed in five patients due to Fontan failure in the early postoperative period, and in five patients in the late period. The median follow-up duration was 2.2 (range, 0.1 to 6) years. Following the procedure, pleural effusion regressed in four patients; median systemic venous pressure decreased by 3.4 (range, 2 to 9) mmHg, while median oxygen saturation dropped by 5.9% (range, 3 to 9%). Clinical improvement was observed in 70% of the patients within the first month. However, one patient died on postoperative Day 44 due to low cardiac output. Fenestration was performed in three patients with protein-losing enteropathy, and clinical improvement was achieved in all of them.

Conclusion: Transcatheter Fontan fenestration is a reliable therapeutic option for reducing systemic venous pressure and achieving hemodynamic improvement in symptomatic Fontan patients. Our study highlights the low complication rates and the potential of this procedure to yield favorable clinical outcomes. Transcatheter fenestration plays an important role in the management of high-risk Fontan patients.

背景:我们研究的目的是评估经导管开窗对Fontan衰竭患者的血流动力学影响和临床结果。方法:回顾性分析2014年1月至2022年12月行Fontan手术的187例患者中,因Fontan衰竭发生而行经导管造瘘或扩大Fontan开窗的10例患者(男6例,女4例,中位年龄10.9岁,年龄范围4.2 ~ 23岁)。记录患者的人口学资料、实验室结果、超声心动图结果和导管参数。根据Fontan衰竭时间将患者分为两组,出院前开窗者为早期组,出院后开窗者为晚期组。比较两组患者血流动力学参数、血氧饱和度变化及并发症发生率。结果:5例因Fontan失效患者术后早期行经导管开窗,5例术后晚期行经导管开窗。中位随访时间为2.2年(范围0.1至6年)。手术后,4例患者胸腔积液消退;中位全身静脉压下降3.4 mmHg(范围2 ~ 9),中位血氧饱和度下降5.9%(范围3 ~ 9%)。70%的患者在第一个月内观察到临床改善。然而,有1例患者因低心输出量在术后第44天死亡。对3例蛋白丢失性肠病患者进行开窗治疗,均获得临床改善。结论:经导管Fontan开窗治疗是一种可靠的治疗选择,可降低系统性静脉压,改善有症状的Fontan患者的血流动力学。我们的研究强调了低并发症率和这种手术产生良好临床结果的潜力。经导管开窗在高危Fontan患者的治疗中起着重要的作用。
{"title":"Transcatheter fenestration in Fontan failure: Our clinical experience.","authors":"Ensar Duras, Recep Siyar Balik, Perver Arslan, Erman Cilsal, Murat Sahin, Ibrahim Cansaran Tanidir, Yakup Ergul, Alper Guzeltas","doi":"10.5606/tgkdc.dergisi.2025.27159","DOIUrl":"10.5606/tgkdc.dergisi.2025.27159","url":null,"abstract":"<p><strong>Background: </strong>The aim of our study was to evaluate the hemodynamic effects and clinical outcomes of transcatheter fenestration in patients who developed Fontan failure.</p><p><strong>Methods: </strong>Between January 2014 and December 2022, among a total of 187 patients undergoing the Fontan operation, 10 (6 males, 4 females; median age: 10.9 years; range, 4.2 to 23 years) who underwent transcatheter creation or dilation of a Fontan fenestration due to the development of Fontan failure were retrospectively analyzed. Demographic data, laboratory results, echocardiographic findings, and catheterization parameters of the patients were recorded. The patients were classified into two groups based on the timing of Fontan failure: those who underwent fenestration before hospital discharge constituted the early-stage group, while those who underwent fenestration after discharge were assigned to the late-stage group. These two groups were compared in terms of hemodynamic parameters, changes in oxygen saturation, and complication rates.</p><p><strong>Results: </strong>Transcatheter fenestration was performed in five patients due to Fontan failure in the early postoperative period, and in five patients in the late period. The median follow-up duration was 2.2 (range, 0.1 to 6) years. Following the procedure, pleural effusion regressed in four patients; median systemic venous pressure decreased by 3.4 (range, 2 to 9) mmHg, while median oxygen saturation dropped by 5.9% (range, 3 to 9%). Clinical improvement was observed in 70% of the patients within the first month. However, one patient died on postoperative Day 44 due to low cardiac output. Fenestration was performed in three patients with protein-losing enteropathy, and clinical improvement was achieved in all of them.</p><p><strong>Conclusion: </strong>Transcatheter Fontan fenestration is a reliable therapeutic option for reducing systemic venous pressure and achieving hemodynamic improvement in symptomatic Fontan patients. Our study highlights the low complication rates and the potential of this procedure to yield favorable clinical outcomes. Transcatheter fenestration plays an important role in the management of high-risk Fontan patients.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"288-300"},"PeriodicalIF":0.5,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Telerehabilitation for thoracic surgery patients: An effective alternative during the pandemic. 胸外科手术患者远程康复:大流行期间的一种有效选择
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-06-27 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.27287
Esra Pehlivan, Burcu Kılıç, Ayça Evkaya Acar, Yaman Khoraki, Sibel Gayretli Atan, Akif Turna

Background: This study aims to evaluate the effectiveness of application of physiotherapy via remote telerehabilitation in the early postoperative period following thoracic surgery.

Methods: Between October 2020 and July 2024, a total of 40 patients (25 males, 15 females; mean age: 57.8±9.6 years; range, 42 to 77 years) who underwent thoracic surgery due to Stage 1A-3B non-small cell lung cancer were included in this randomized-controlled clinical study. The patients were divided into two groups: the telerehabilitation group (TG, n=20) and the control group (CG, n=20). Patients in the TG participated in a teleconference-based exercise program supervised by a physiotherapist, starting the day before surgery and continuing daily until discharge. Patients in the CG received a single preoperative exercise session and an educational brochure. All patients were assessed at five time points: preoperatively, immediately after surgery, prior to discharge, at one to three months post-discharge, and at six months post-discharge. Outcome measures included the duration of intensive care unit stay, total hospital stay, chest drain duration, postoperative complications, inflammatory biomarkers, pain, dyspnea, fatigue, spirometry, and State-Trait Anxiety Inventory (STAI) scores.

Results: Both groups had similar baseline characteristics including comorbidities and types of surgery (p>0.05). There were no significant differences in the intensive care unit stay duration (p=0.739), total hospital stay (p=0.311), or chest drain duration (p=0.431) between the groups. However, TG showed significantly lower pain and fatigue levels compared to CG (p<0.05).

Conclusion: Telerehabilitation effectively reduced pain and fatigue in patients after thoracic surgery. The lack of significant differences in other outcomes may be attributed to variations in patient compliance. These findings suggest that telerehabilitation can be a valuable alternative to traditional rehabilitation, particularly during pandemic or isolation.

背景:本研究旨在评价胸外科术后早期应用远程康复物理治疗的效果。方法:本随机对照临床研究纳入2020年10月至2024年7月期间因1A-3B期非小细胞肺癌行胸外科手术的患者40例(男性25例,女性15例,平均年龄57.8±9.6岁,42 ~ 77岁)。将患者分为两组:远程康复组(TG, n=20)和对照组(CG, n=20)。TG组的患者在物理治疗师的监督下参加了一个基于远程会议的锻炼计划,从手术前一天开始,每天持续到出院。CG组的患者只接受一次术前锻炼和一本教育手册。所有患者在五个时间点进行评估:术前、术后、出院前、出院后1至3个月和出院后6个月。结果测量包括重症监护病房住院时间、总住院时间、胸腔引流时间、术后并发症、炎症生物标志物、疼痛、呼吸困难、疲劳、肺活量测定和状态-特质焦虑量表(STAI)评分。结果:两组具有相似的基线特征,包括合并症和手术类型(p < 0.05)。两组间重症监护病房住院时间(p=0.739)、总住院时间(p=0.311)和胸腔引流时间(p=0.431)均无显著差异。然而,与CG相比,TG的疼痛和疲劳水平明显降低(p结论:远程康复能有效减轻胸外科术后患者的疼痛和疲劳。其他结果缺乏显著差异可能归因于患者依从性的变化。这些发现表明,远程康复可以成为传统康复的一种有价值的替代方法,特别是在大流行或隔离期间。
{"title":"Telerehabilitation for thoracic surgery patients: An effective alternative during the pandemic.","authors":"Esra Pehlivan, Burcu Kılıç, Ayça Evkaya Acar, Yaman Khoraki, Sibel Gayretli Atan, Akif Turna","doi":"10.5606/tgkdc.dergisi.2025.27287","DOIUrl":"10.5606/tgkdc.dergisi.2025.27287","url":null,"abstract":"<p><strong>Background: </strong>This study aims to evaluate the effectiveness of application of physiotherapy via remote telerehabilitation in the early postoperative period following thoracic surgery.</p><p><strong>Methods: </strong>Between October 2020 and July 2024, a total of 40 patients (25 males, 15 females; mean age: 57.8±9.6 years; range, 42 to 77 years) who underwent thoracic surgery due to Stage 1A-3B non-small cell lung cancer were included in this randomized-controlled clinical study. The patients were divided into two groups: the telerehabilitation group (TG, n=20) and the control group (CG, n=20). Patients in the TG participated in a teleconference-based exercise program supervised by a physiotherapist, starting the day before surgery and continuing daily until discharge. Patients in the CG received a single preoperative exercise session and an educational brochure. All patients were assessed at five time points: preoperatively, immediately after surgery, prior to discharge, at one to three months post-discharge, and at six months post-discharge. Outcome measures included the duration of intensive care unit stay, total hospital stay, chest drain duration, postoperative complications, inflammatory biomarkers, pain, dyspnea, fatigue, spirometry, and State-Trait Anxiety Inventory (STAI) scores.</p><p><strong>Results: </strong>Both groups had similar baseline characteristics including comorbidities and types of surgery (p>0.05). There were no significant differences in the intensive care unit stay duration (p=0.739), total hospital stay (p=0.311), or chest drain duration (p=0.431) between the groups. However, TG showed significantly lower pain and fatigue levels compared to CG (p<0.05).</p><p><strong>Conclusion: </strong>Telerehabilitation effectively reduced pain and fatigue in patients after thoracic surgery. The lack of significant differences in other outcomes may be attributed to variations in patient compliance. These findings suggest that telerehabilitation can be a valuable alternative to traditional rehabilitation, particularly during pandemic or isolation.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"365-374"},"PeriodicalIF":0.5,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421554/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three-dimensional modeling of bronchovascular anatomy for preoperative planning and intraoperative guidance in uniportal video-assisted thoracoscopic segmentectomy. 单门视频胸腔镜肺段切除术中支气管血管解剖三维模型的术前规划及术中指导。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-06-27 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.27289
Selçuk Gürz, Ayşen Şengül

Background: This study aim to evaluate the feasibility of threedimensional (3D) modeling using open-source free software for preoperative planning and intraoperative guidance in uniportal video-assisted thoracoscopic segmentectomies.

Methods: Between October 2020 and November 2023, 50 patients (27 males, 23 females; mean age: 60±11.1 years; range, 34 to 78 years) who underwent uniportal video-assisted thoracoscopic pulmonary segmentectomy with preoperative 3D modeling were retrospectively analyzed. Preoperative 3D modeling was performed using computed tomography with an open-source 3D software program. The virtual models exported to the mobile device were compared with the anatomical structures of the patient intraoperatively. The patients were divided into two groups as simple and complex segmentectomy according to the characteristics of the surgical procedures.

Results: The overall matching success rate of the virtual 3D models with intraoperatively identified bronchovascular structures was 99.27%. The overall variation rate was 36% (n=18) among all patients. There was a significant difference between the two groups in terms of the bronchovascular variation. The bronchovascular variation rate was 11.1% (n=2) in Group 1 and 50% (n=16) in Group 2 (p=0.006).

Conclusion: Three-dimensional modeling using open-source software for preoperative planning and intraoperative guidance is a reliable method for detecting bronchovascular structures of the target segment with high accuracy in uniportal video-assisted thoracoscopic surgery segmentectomy.

背景:本研究旨在评估使用开源免费软件进行三维(3D)建模用于单门静脉视频胸腔镜节段切除术术前规划和术中指导的可行性。方法:回顾性分析2020年10月至2023年11月行单门电视胸腔镜肺段切除术的患者50例(男性27例,女性23例,平均年龄60±11.1岁,年龄范围34 ~ 78岁),术前3D建模。术前3D建模使用计算机断层扫描和开源3D软件程序。导出到移动设备的虚拟模型与患者术中解剖结构进行比较。根据手术方式的特点,将患者分为简单节段切除术和复杂节段切除术两组。结果:虚拟三维模型与术中识别的支气管血管结构总体匹配成功率为99.27%。所有患者的总体变异率为36% (n=18)。两组在支气管血管变异方面有显著差异。1组支气管血管变异率为11.1% (n=2), 2组为50% (n=16),差异有统计学意义(p=0.006)。结论:利用开源软件进行三维建模,进行术前规划和术中指导,是单门静脉胸腔镜手术节段切除术中检测目标节段支气管血管结构的可靠方法,准确率高。
{"title":"Three-dimensional modeling of bronchovascular anatomy for preoperative planning and intraoperative guidance in uniportal video-assisted thoracoscopic segmentectomy.","authors":"Selçuk Gürz, Ayşen Şengül","doi":"10.5606/tgkdc.dergisi.2025.27289","DOIUrl":"10.5606/tgkdc.dergisi.2025.27289","url":null,"abstract":"<p><strong>Background: </strong>This study aim to evaluate the feasibility of threedimensional (3D) modeling using open-source free software for preoperative planning and intraoperative guidance in uniportal video-assisted thoracoscopic segmentectomies.</p><p><strong>Methods: </strong>Between October 2020 and November 2023, 50 patients (27 males, 23 females; mean age: 60±11.1 years; range, 34 to 78 years) who underwent uniportal video-assisted thoracoscopic pulmonary segmentectomy with preoperative 3D modeling were retrospectively analyzed. Preoperative 3D modeling was performed using computed tomography with an open-source 3D software program. The virtual models exported to the mobile device were compared with the anatomical structures of the patient intraoperatively. The patients were divided into two groups as simple and complex segmentectomy according to the characteristics of the surgical procedures.</p><p><strong>Results: </strong>The overall matching success rate of the virtual 3D models with intraoperatively identified bronchovascular structures was 99.27%. The overall variation rate was 36% (n=18) among all patients. There was a significant difference between the two groups in terms of the bronchovascular variation. The bronchovascular variation rate was 11.1% (n=2) in Group 1 and 50% (n=16) in Group 2 (p=0.006).</p><p><strong>Conclusion: </strong>Three-dimensional modeling using open-source software for preoperative planning and intraoperative guidance is a reliable method for detecting bronchovascular structures of the target segment with high accuracy in uniportal video-assisted thoracoscopic surgery segmentectomy.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"341-348"},"PeriodicalIF":0.5,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421563/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival analysis between single-factor and multi-factor groups in Stage T3N0M0 non-small cell lung cancer. T3N0M0期非小细胞肺癌单因素组与多因素组的生存分析。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-06-27 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.26607
İsmail Tombul, Muhammet Sayan, Şevki Mustafa Demiröz, Ali Çelik, İsmail Cüneyt Kurul, Abdullah İrfan Taştepe, Olgun Kadir Arıbaş

Background: This study aims to identify prognostic factors in operated patients with non-small cell lung cancer staged as T3N0M0 according to the 8th edition of the Tumor, Node, Metastasis (TNM) staging system.

Methods: Between January 2010 and June 2023, a total of 79 patients (67 males, 12 females; mean age: 62.9±8.7; range, 40 to 80 years) who underwent surgery for non-small cell lung cancer and were pathologically staged as T3N0M0 were retrospectively analyzed. The patients were divided into two groups: the first group included 56 patients with a single T3 factor, while the second group included 23 patients with multiple T3 factors. Survival analysis was performed.

Results: The five-year overall survival rate for the first group was 79.0%, with a mean overall survival of 107.76±8.44 months (95% confidence interval [CI]: 91.21-124.32), while the second group had a five-year overall survival rate of 48.9%, with a mean overall survival of 69.19±12.60 months (95% CI: 44.48-93.91). This difference was statistically significant (p=0.02). In the multivariate analysis, multiple T3 factors (p=0.003) and the presence of comorbidity (p=0.004) were found to be independent poor prognostic factors.

Conclusion: Our study results suggest that having multiple T factors significantly and adversely affect survival of patients with surgically treated pT3 non-small cell lung cancer.

背景:本研究旨在根据第8版肿瘤、淋巴结、转移(Tumor, Node, Metastasis, TNM)分期系统,确定手术后分期为T3N0M0的非小细胞肺癌患者的预后影响因素。方法:回顾性分析2010年1月~ 2023年6月79例非小细胞肺癌手术患者,其中男性67例,女性12例,平均年龄62.9±8.7岁,年龄范围40 ~ 80岁,病理分期为T3N0M0。将患者分为两组,第一组56例合并单一T3因素,第二组23例合并多种T3因素。进行生存分析。结果:第一组患者5年总生存率为79.0%,平均总生存率为107.76±8.44个月(95%可信区间[CI]: 91.21 ~ 124.32);第二组患者5年总生存率为48.9%,平均总生存率为69.19±12.60个月(95% CI: 44.48 ~ 93.91)。差异有统计学意义(p=0.02)。在多因素分析中,发现多个T3因素(p=0.003)和存在合并症(p=0.004)是独立的不良预后因素。结论:我们的研究结果表明,多种T因子对手术治疗的pT3型非小细胞肺癌患者的生存有显著的不利影响。
{"title":"Survival analysis between single-factor and multi-factor groups in Stage T3N0M0 non-small cell lung cancer.","authors":"İsmail Tombul, Muhammet Sayan, Şevki Mustafa Demiröz, Ali Çelik, İsmail Cüneyt Kurul, Abdullah İrfan Taştepe, Olgun Kadir Arıbaş","doi":"10.5606/tgkdc.dergisi.2025.26607","DOIUrl":"10.5606/tgkdc.dergisi.2025.26607","url":null,"abstract":"<p><strong>Background: </strong>This study aims to identify prognostic factors in operated patients with non-small cell lung cancer staged as T3N0M0 according to the 8<sup>th</sup> edition of the Tumor, Node, Metastasis (TNM) staging system.</p><p><strong>Methods: </strong>Between January 2010 and June 2023, a total of 79 patients (67 males, 12 females; mean age: 62.9±8.7; range, 40 to 80 years) who underwent surgery for non-small cell lung cancer and were pathologically staged as T3N0M0 were retrospectively analyzed. The patients were divided into two groups: the first group included 56 patients with a single T3 factor, while the second group included 23 patients with multiple T3 factors. Survival analysis was performed.</p><p><strong>Results: </strong>The five-year overall survival rate for the first group was 79.0%, with a mean overall survival of 107.76±8.44 months (95% confidence interval [CI]: 91.21-124.32), while the second group had a five-year overall survival rate of 48.9%, with a mean overall survival of 69.19±12.60 months (95% CI: 44.48-93.91). This difference was statistically significant (p=0.02). In the multivariate analysis, multiple T3 factors (p=0.003) and the presence of comorbidity (p=0.004) were found to be independent poor prognostic factors.</p><p><strong>Conclusion: </strong>Our study results suggest that having multiple T factors significantly and adversely affect survival of patients with surgically treated pT3 non-small cell lung cancer.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"349-356"},"PeriodicalIF":0.5,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421539/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare non-thrombotic pulmonary artery embolism: A pelvic coil. 罕见的非血栓性肺动脉栓塞:盆腔线圈。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-06-27 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.27268
Ömer Faruk Aktaş, Derya Balcı Köroğlu, Koray Dural
{"title":"Rare non-thrombotic pulmonary artery embolism: A pelvic coil.","authors":"Ömer Faruk Aktaş, Derya Balcı Köroğlu, Koray Dural","doi":"10.5606/tgkdc.dergisi.2025.27268","DOIUrl":"10.5606/tgkdc.dergisi.2025.27268","url":null,"abstract":"","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"395-396"},"PeriodicalIF":0.5,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparison of preoperative chemoradiotherapy versus primary surgery for T4 non-small cell lung cancer. 术前放化疗与原发性手术治疗T4非小细胞肺癌的比较。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-06-27 eCollection Date: 2025-07-01 DOI: 10.5606/tgkdc.dergisi.2025.27574
Oğuzhan Turan, Leyla Hasdıraz, Sezer Aslan, Omer Faruk Demir, Omer Onal, Celalettin Eroğlu

Background: In this study, we aimed to compare the outcomes of patients who underwent surgery after neoadjuvant chemoradiotherapy versus primary surgery in locally advanced T4 non-small cell lung cancer.

Methods: Between January 2010 and January 2020, a total of 71 non-small cell lung cancer patients (63 males, 8 females; mean age: 57.9±9.6 years; range, 34 to 76 years) diagnosed with T4 tumors and underwent surgery were retrospectively analyzed. Of these patients, 50 underwent neoadjuvant therapy before surgical resection (Group 1), while 21 underwent surgical resection alone (Group 2). Demographic characteristics, complications, mortality and pathological examination results of the patients were recorded.

Results: The neoadjuvant therapy group exhibited a significantly lower mortality rate (odds ratio=4.3). Age and neoadjuvant treatment were the most significant factors on mortality. Overall survival was longer among patients receiving neoadjuvant chemoradiotherapy, but not statistically significant (80.5±9.9 months vs. 60.9±7.9 months, p=0.081).

Conclusion: Our study results indicated a substantial reduction in mortality rates among patients with T4 tumors who underwent concurrent neoadjuvant chemoradiotherapy. Based on these results, neoadjuvant treatment serves as a beneficial preoperative intervention for eligible patients and should be considered before surgical resection.

背景:在本研究中,我们旨在比较局部晚期T4非小细胞肺癌患者在新辅助放化疗后接受手术与原发性手术的结果。方法:回顾性分析2010年1月至2020年1月诊断为T4肿瘤并行手术治疗的非小细胞肺癌患者71例(男63例,女8例,平均年龄57.9±9.6岁,年龄范围34 ~ 76岁)。其中50例患者术前行新辅助治疗(1组),21例患者单独行手术切除(2组)。记录患者的人口学特征、并发症、死亡率及病理检查结果。结果:新辅助治疗组死亡率明显降低(优势比=4.3)。年龄和新辅助治疗是影响死亡率的最重要因素。接受新辅助放化疗的患者总生存期更长,但无统计学意义(80.5±9.9个月比60.9±7.9个月,p=0.081)。结论:我们的研究结果表明,同时接受新辅助放化疗的T4肿瘤患者死亡率显著降低。基于这些结果,对于符合条件的患者,新辅助治疗是一种有益的术前干预措施,在手术切除前应予以考虑。
{"title":"A comparison of preoperative chemoradiotherapy versus primary surgery for T4 non-small cell lung cancer.","authors":"Oğuzhan Turan, Leyla Hasdıraz, Sezer Aslan, Omer Faruk Demir, Omer Onal, Celalettin Eroğlu","doi":"10.5606/tgkdc.dergisi.2025.27574","DOIUrl":"10.5606/tgkdc.dergisi.2025.27574","url":null,"abstract":"<p><strong>Background: </strong>In this study, we aimed to compare the outcomes of patients who underwent surgery after neoadjuvant chemoradiotherapy versus primary surgery in locally advanced T4 non-small cell lung cancer.</p><p><strong>Methods: </strong>Between January 2010 and January 2020, a total of 71 non-small cell lung cancer patients (63 males, 8 females; mean age: 57.9±9.6 years; range, 34 to 76 years) diagnosed with T4 tumors and underwent surgery were retrospectively analyzed. Of these patients, 50 underwent neoadjuvant therapy before surgical resection (Group 1), while 21 underwent surgical resection alone (Group 2). Demographic characteristics, complications, mortality and pathological examination results of the patients were recorded.</p><p><strong>Results: </strong>The neoadjuvant therapy group exhibited a significantly lower mortality rate (odds ratio=4.3). Age and neoadjuvant treatment were the most significant factors on mortality. Overall survival was longer among patients receiving neoadjuvant chemoradiotherapy, but not statistically significant (80.5±9.9 months vs. 60.9±7.9 months, p=0.081).</p><p><strong>Conclusion: </strong>Our study results indicated a substantial reduction in mortality rates among patients with T4 tumors who underwent concurrent neoadjuvant chemoradiotherapy. Based on these results, neoadjuvant treatment serves as a beneficial preoperative intervention for eligible patients and should be considered before surgical resection.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 3","pages":"375-381"},"PeriodicalIF":0.5,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12421548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145041751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral ovarian vein coil embolization with crossover technique in pelvic venous disease: One year follow-up results. 交叉技术双侧卵巢静脉线圈栓塞治疗盆腔静脉疾病:一年随访结果。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-04-30 eCollection Date: 2025-04-01 DOI: 10.5606/tgkdc.dergisi.2025.27100
Serkan Ketenciler, Mehmet Ali Yeşiltaş, Ahmet Ozan Koyuncu, Özgür Gursu, İlhan Sanisoğlu

Background: In this study, we aimed to evaluate one-year clinical follow-up of patients who underwent bilateral ovarian vein embolization using crossover maneuvers between the ovarian veins via unilateral puncture.

Methods: Between January 2017 and September 2022, a total of 34 women (mean age: 39.6±4.9 years; range, 26 to 52 years) who had pelvic venous disease and underwent bilateral embolization of ovarian veins with unilateral puncture and collateral crossover were retrospectively analyzed. The patients were followed at one, six, and 12 months postoperatively. Symptoms were evaluated using physical examination findings and Visual Analog Scale scores and the need for reintervention was assessed.

Results: Of a total of 34 patients, 21 (61.8%) reported dysmenorrhea and 18 (53%) reported both dyspareunia and lower limb varices. There were no major complications during the procedure. The mean preoperative Visual Analog Scale score was 8.1±0.8, which decreased to 2.1±0.6 at 12 months. Reintervention was necessary for only one patient during one-year follow-up.

Conclusion: Although bilateral ovarian vein embolization with crossover to the contralateral side poses greater technical challenges than unilateral ovarian vein closure, it remains a viable technique with favorable outcomes and lower complication rates.

背景:在这项研究中,我们旨在评估通过单侧穿刺卵巢静脉间交叉操作进行双侧卵巢静脉栓塞的患者一年的临床随访。方法:2017年1月至2022年9月,共34例女性(平均年龄:39.6±4.9岁;回顾性分析了26 ~ 52岁的盆腔静脉疾病患者,并通过单侧穿刺和侧支交叉进行双侧卵巢静脉栓塞。分别于术后1、6、12个月进行随访。使用体格检查结果和视觉模拟量表评分评估症状,并评估再干预的必要性。结果:在34例患者中,21例(61.8%)报告痛经,18例(53%)报告性交困难和下肢静脉曲张。手术过程中没有出现重大并发症。术前平均视觉模拟量表评分为8.1±0.8,12个月时降至2.1±0.6。在一年的随访中,只有1例患者需要再干预。结论:虽然双侧卵巢静脉栓塞术与单侧卵巢静脉栓塞术相比技术挑战更大,但仍是一种可行的技术,效果良好,并发症发生率低。
{"title":"Bilateral ovarian vein coil embolization with crossover technique in pelvic venous disease: One year follow-up results.","authors":"Serkan Ketenciler, Mehmet Ali Yeşiltaş, Ahmet Ozan Koyuncu, Özgür Gursu, İlhan Sanisoğlu","doi":"10.5606/tgkdc.dergisi.2025.27100","DOIUrl":"10.5606/tgkdc.dergisi.2025.27100","url":null,"abstract":"<p><strong>Background: </strong>In this study, we aimed to evaluate one-year clinical follow-up of patients who underwent bilateral ovarian vein embolization using crossover maneuvers between the ovarian veins via unilateral puncture.</p><p><strong>Methods: </strong>Between January 2017 and September 2022, a total of 34 women (mean age: 39.6±4.9 years; range, 26 to 52 years) who had pelvic venous disease and underwent bilateral embolization of ovarian veins with unilateral puncture and collateral crossover were retrospectively analyzed. The patients were followed at one, six, and 12 months postoperatively. Symptoms were evaluated using physical examination findings and Visual Analog Scale scores and the need for reintervention was assessed.</p><p><strong>Results: </strong>Of a total of 34 patients, 21 (61.8%) reported dysmenorrhea and 18 (53%) reported both dyspareunia and lower limb varices. There were no major complications during the procedure. The mean preoperative Visual Analog Scale score was 8.1±0.8, which decreased to 2.1±0.6 at 12 months. Reintervention was necessary for only one patient during one-year follow-up.</p><p><strong>Conclusion: </strong>Although bilateral ovarian vein embolization with crossover to the contralateral side poses greater technical challenges than unilateral ovarian vein closure, it remains a viable technique with favorable outcomes and lower complication rates.</p>","PeriodicalId":49413,"journal":{"name":"Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery","volume":"33 2","pages":"176-184"},"PeriodicalIF":0.5,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12188967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144509141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal of Thoracic and Cardiovascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1